Endoscopic treatment of vesicoureteral reflux using cross-linked bovine dermal collagen

Marc Cendron, Michael P. Leonard, John Phillip Gearhart, Robert D. Jeffs

Research output: Contribution to journalArticle

Abstract

To assess the efficacy of endoscopic treatment of vesicoureteral reflux (VUR) with cross-linked bovine collagen, 59 patients with grade I through V VUR were evaluated and treated. Follow-up consisted of a voiding cystourethrogram and renal ultrasound at 1 month and 1 year with urinalysis and urine culture. Repeat treatment was carried out in cases in which no resolution of the reflux was noted up to three times. The procedure was performed on an outpatient basis in 56 patients and was not associated with any major morbidity or mortality. Cure at 1 month was observed in 75% of ureters treated; cure persisted in 79% of these ureters at 1 year. The overall cure rate was 65% at 1 year. Given the simplicity of the procedure, its low complication rate, and overall success in the majority of patients, we feel that endoscopic treatment of VUR with cross-linked bovine dermal collagen is a safe and effective method and worthy of further study to enhance its efficacy.

Original languageEnglish (US)
Pages (from-to)295-300
Number of pages6
JournalPediatric Surgery International
Volume6
Issue number4-5
DOIs
StatePublished - Jul 1991

Fingerprint

Vesico-Ureteral Reflux
Collagen
Ureter
Skin
Urinalysis
Outpatients
Therapeutics
Urine
Morbidity
Kidney
Mortality

Keywords

  • Collagen
  • Endoscopic treatment
  • Vesicoureteral reflux

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Endoscopic treatment of vesicoureteral reflux using cross-linked bovine dermal collagen. / Cendron, Marc; Leonard, Michael P.; Gearhart, John Phillip; Jeffs, Robert D.

In: Pediatric Surgery International, Vol. 6, No. 4-5, 07.1991, p. 295-300.

Research output: Contribution to journalArticle

Cendron, Marc ; Leonard, Michael P. ; Gearhart, John Phillip ; Jeffs, Robert D. / Endoscopic treatment of vesicoureteral reflux using cross-linked bovine dermal collagen. In: Pediatric Surgery International. 1991 ; Vol. 6, No. 4-5. pp. 295-300.
@article{37f8f65594264fd9988fd30fcc9535bd,
title = "Endoscopic treatment of vesicoureteral reflux using cross-linked bovine dermal collagen",
abstract = "To assess the efficacy of endoscopic treatment of vesicoureteral reflux (VUR) with cross-linked bovine collagen, 59 patients with grade I through V VUR were evaluated and treated. Follow-up consisted of a voiding cystourethrogram and renal ultrasound at 1 month and 1 year with urinalysis and urine culture. Repeat treatment was carried out in cases in which no resolution of the reflux was noted up to three times. The procedure was performed on an outpatient basis in 56 patients and was not associated with any major morbidity or mortality. Cure at 1 month was observed in 75{\%} of ureters treated; cure persisted in 79{\%} of these ureters at 1 year. The overall cure rate was 65{\%} at 1 year. Given the simplicity of the procedure, its low complication rate, and overall success in the majority of patients, we feel that endoscopic treatment of VUR with cross-linked bovine dermal collagen is a safe and effective method and worthy of further study to enhance its efficacy.",
keywords = "Collagen, Endoscopic treatment, Vesicoureteral reflux",
author = "Marc Cendron and Leonard, {Michael P.} and Gearhart, {John Phillip} and Jeffs, {Robert D.}",
year = "1991",
month = "7",
doi = "10.1007/BF00178641",
language = "English (US)",
volume = "6",
pages = "295--300",
journal = "Pediatric Surgery International",
issn = "0179-0358",
publisher = "Springer Verlag",
number = "4-5",

}

TY - JOUR

T1 - Endoscopic treatment of vesicoureteral reflux using cross-linked bovine dermal collagen

AU - Cendron, Marc

AU - Leonard, Michael P.

AU - Gearhart, John Phillip

AU - Jeffs, Robert D.

PY - 1991/7

Y1 - 1991/7

N2 - To assess the efficacy of endoscopic treatment of vesicoureteral reflux (VUR) with cross-linked bovine collagen, 59 patients with grade I through V VUR were evaluated and treated. Follow-up consisted of a voiding cystourethrogram and renal ultrasound at 1 month and 1 year with urinalysis and urine culture. Repeat treatment was carried out in cases in which no resolution of the reflux was noted up to three times. The procedure was performed on an outpatient basis in 56 patients and was not associated with any major morbidity or mortality. Cure at 1 month was observed in 75% of ureters treated; cure persisted in 79% of these ureters at 1 year. The overall cure rate was 65% at 1 year. Given the simplicity of the procedure, its low complication rate, and overall success in the majority of patients, we feel that endoscopic treatment of VUR with cross-linked bovine dermal collagen is a safe and effective method and worthy of further study to enhance its efficacy.

AB - To assess the efficacy of endoscopic treatment of vesicoureteral reflux (VUR) with cross-linked bovine collagen, 59 patients with grade I through V VUR were evaluated and treated. Follow-up consisted of a voiding cystourethrogram and renal ultrasound at 1 month and 1 year with urinalysis and urine culture. Repeat treatment was carried out in cases in which no resolution of the reflux was noted up to three times. The procedure was performed on an outpatient basis in 56 patients and was not associated with any major morbidity or mortality. Cure at 1 month was observed in 75% of ureters treated; cure persisted in 79% of these ureters at 1 year. The overall cure rate was 65% at 1 year. Given the simplicity of the procedure, its low complication rate, and overall success in the majority of patients, we feel that endoscopic treatment of VUR with cross-linked bovine dermal collagen is a safe and effective method and worthy of further study to enhance its efficacy.

KW - Collagen

KW - Endoscopic treatment

KW - Vesicoureteral reflux

UR - http://www.scopus.com/inward/record.url?scp=0025824403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025824403&partnerID=8YFLogxK

U2 - 10.1007/BF00178641

DO - 10.1007/BF00178641

M3 - Article

AN - SCOPUS:0025824403

VL - 6

SP - 295

EP - 300

JO - Pediatric Surgery International

JF - Pediatric Surgery International

SN - 0179-0358

IS - 4-5

ER -